• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Dr. Chiaravalloti receives grant to improve new learning and memory in multiple sclerosis

Bioengineer by Bioengineer
July 24, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The National Institutes of Health awarded a $1,825,742 grant to Nancy Chiaravalloti, PhD, of Kessler Foundation to conduct a randomized controlled trial of strategy-based cognitive training in individuals with cognitive deficits due to multiple sclerosis

IMAGE

Credit: Kessler Foundation

East Hanover, N.J., July 24, 2019. — Nancy Chiaravalloti, PhD, director of the Centers for Neuropsychology, Neuroscience and Traumatic Brain Injury Research at Kessler Foundation, was awarded a $1,825,742 R01 grant by the National Institutes of Health for the study entitled, “Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in Multiple Sclerosis.”

Impairments in new learning and memory negatively affect the everyday lives of many individuals with multiple sclerosis, including their ability to function effectively in work and social settings. Few individuals receive treatment for these impairments because of the Lack of Class I evidence for targeted cognitive rehabilitation interventions. To address the pressing need for such evidence, the Kessler team will conduct a double-blinded, placebo-controlled, randomized controlled trial of 120 participants with multiple sclerosis and deficits in learning and memory.

This study builds on the substantial body of research in memory rehabilitation conducted at Kessler Foundation by Dr. Chiaravalloti and colleagues. “Our study examines the efficacy of strategy-based training to enhance memory, or STEM”, Dr. Chiaravalloti explained. “The 8-session protocol encompasses the three strategies we have determined to have the greatest empirical evidence for treating impaired learning and memory: self-generation, spaced learning and self-testing.”

The researchers will measure the study’s outcomes using three methods — an Assessment of Global Functioning, which examines everyday functioning and quality of life, a Neuropsychological Evaluation to examine objective cognitive performance; and neuroimaging to elucidate the neural mechanisms of STEM. The neuroimaging studies will be conducted at the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, a research-dedicated facility.

Including the examination of daily life activities as an endpoint is an innovative aspect of the study, according to Dr. Chiaravalloti. “Our main goal is to develop a treatment that improves how individuals function at home, in the workplace, and in their communities.”

“The study includes a six-month follow-up evaluation,” she said, “so we can assess the longer-term efficacy of STEM on the participants’ everyday functioning and their neuropsychological performance. We will also evaluate the impact of booster sessions in maintaining the treatment effect over time. We anticipate that this rigorous protocol will yield Class 1 evidence for the efficacy of STEM treatment for the cognitive impairments of multiple sclerosis. “

###

Funded by National Institutes of Health R01HD095915

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities.

For more information on Kessler Foundation’s research, visit KesslerFoundation.org.

Facebook |http://www.facebook.com/KesslerFoundation

Twitter | http://twitter.com/KesslerFdn

Instagram | https://www.instagram.com/kesslerfdn

YouTube | http://www.youtube.com/user/KesslerFoundation

iTunes & SoundCloud | http://www.soundcloud.com/kesslerfoundation

Press Contacts

Carolann Murphy, PA

Senior Staff Writer

973.324.8382

[email protected]

Rob Gerth

Director, Communications

973.323.3675

[email protected]

Media Contact
Carolann Murphy
[email protected]

Tags: Clinical TrialsDisabled PersonsHealth CareLearning/Literacy/ReadingMemory/Cognitive ProcessesneurobiologyQuality of LifeRehabilitation/Prosthetics/Plastic SurgerySocial/Behavioral Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Overcoming Challenges in Metastatic Prostate Cancer Care

October 2, 2025

Kirigami Parachutes Enable Programmable Reconfiguration

October 2, 2025

Trimodal Protein Language Model Powers Advanced Searches

October 2, 2025

Pathogenic Variants Identify Prostate Cancer Genes in African Men

October 2, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    91 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    64 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Overcoming Challenges in Metastatic Prostate Cancer Care

Utilizing Weighted Cox Regression in Time-to-Event Studies

Kirigami Parachutes Enable Programmable Reconfiguration

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.